Tracy McIlwean
Nurse Practitioner · New Bern, NCNPI 1104426584
Payments from drug & device makers
Across 133 payments — averaging $35.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Si-bone, Inc.$1K
- Relievant Medsystems, Inc.$1K
- Collegium Pharmaceutical, Inc.$298
- AbbVie$274
- Nevro Corp.$264
- Boston Scientific$255
- plus $1K from 24 others
What the payments were for
- Travel & lodging$1,66436%
- Food & beverage$2,99564%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Si-bone, Inc. | 8 | $1,214 |
| Relievant Medsystems, Inc. | 13 | $1,201 |
| Collegium Pharmaceutical, Inc. | 17 | $298 |
| AbbVie(2 entities) | 14 | $274 |
| Nevro Corp. | 8 | $264 |
| Boston Scientific | 13 | $255 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $133 |
| GRT US Holding, Inc. | 3 | $101 |
| Almatica Pharma LLC | 4 | $82 |
| Forte Bio-pharma LLC | 3 | $77 |
| Lundbeck LLC | 3 | $72 |
| Biohaven Pharmaceuticals, Inc. | 5 | $65 |
| Virtus Pharmaceuticals LLC | 3 | $61 |
| Pfizer | 4 | $56 |
| Saluda Medical Americas, Inc. | 3 | $53 |
| Arbor Pharmaceuticals, Inc. | 4 | $52 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $45 |
| Valinor Pharma, LLC | 2 | $41 |
| Fidia Pharma USA Inc. | 2 | $40 |
| Scilex Pharmaceuticals Inc. | 2 | $39 |
| Biodelivery Sciences International, Inc. | 3 | $39 |
| Averitas Pharma Inc. | 1 | $31 |
| Novo Nordisk | 2 | $27 |
| Amgen | 1 | $26 |
| Medtronic | 1 | $23 |
| Hikma Pharmaceuticals USA | 1 | $22 |
| Redhill Biopharma Inc. | 1 | $21 |
| Baudax Bio Inc. | 1 | $20 |
| Azurity Pharmaceuticals, Inc. | 1 | $13 |
| Vertos Medical, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$1,902
- IFUSE IMPLANT SYSTEM$951
- Omnia$120
How this compares
$4,658 in reported general payments places this provider in the 90th percentile of 4,393 nurse practitioner providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 28 | $20,225 |
| MovantikNaloxegol Oxalate | 17 | $6,945 |
| Oxycodone Hcl | 281 | $6,182 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 170 | $6,135 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 219 | $5,297 |
| Buprenorphine | 12 | $3,969 |
| Pregabalin | 79 | $2,478 |
| Morphine Sulfate ErMorphine Sulfate | 105 | $2,369 |
| Tramadol Hcl ErTramadol Hcl | 31 | $2,089 |
| Gabapentin | 117 | $1,245 |
| Fentanyl | 11 | $932 |
| Tramadol Hcl | 80 | $835 |
| Tizanidine Hcl | 57 | $782 |
| Methadone Hcl | 19 | $360 |
| Diclofenac Sodium | 15 | $331 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $298 | $20,22528 claims |
| Redhill Biopharma Inc.Movantik | $21 | $6,94517 claims |
| Hikma Pharmaceuticals USABuprenorphine | $22 | $3,96912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,393 nurse practitioner providers in North Carolina.
Other nurse practitioner in New Bern
- Vinetta McCannNew Bern$16K
- Sandrivette JohnsonRaleigh$573K
- Skyler RogersPinehurst$174K
- Jamie DinerDurham$170K
- Ayeshia WrightMocksville$145K
- Deborah AllenDurham$112K
- Jeanann VawterGastonia$97K
- Terra KampJacksonville$72K
- Mary DilorenzoCharlotte$71K
- Olivia OgburnWinston Salem$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.